Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Gross Profit (2016 - 2026)

Pharma-Bio Serv's Gross Profit history spans 16 years, with the latest figure at $722374.0 for Q1 2026.

  • For Q1 2026, Gross Profit fell 5.95% year-over-year to $722374.0; the TTM value through Jan 2026 reached $2.9 million, up 4.21%, while the annual FY2025 figure was $2.9 million, 15.66% up from the prior year.
  • Gross Profit reached $722374.0 in Q1 2026 per PBSV's latest filing, down from $748935.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.6 million in Q3 2023 to a low of $535609.0 in Q1 2024.
  • Average Gross Profit over 5 years is $946841.4, with a median of $818726.0 recorded in 2025.
  • Peak YoY movement for Gross Profit: crashed 59.01% in 2024, then soared 43.41% in 2025.
  • A 5-year view of Gross Profit shows it stood at $1.1 million in 2022, then dropped by 16.13% to $929805.0 in 2023, then fell by 21.86% to $726570.0 in 2024, then rose by 3.08% to $748935.0 in 2025, then dropped by 3.55% to $722374.0 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Gross Profit are $722374.0 (Q1 2026), $748935.0 (Q4 2025), and $574262.0 (Q3 2025).